IMPORTANCE Healthcare overuse, the delivery of low-value services, is increasingly recognized as a critical problem. However, little is known about the comparative effectiveness of alternate formats for presenting benefits and harms information to patients as a strategy to reduce overuse.
However, the best ways to address health care overuse are unknown. It is unclear whether the same strategies that increase use of effective health care services work equally well to reduce overuse of health care services. 4 Furthermore, little comparative effectiveness research is available to guide prevention and deimplementation of strategies targeted at overuse. 5, 6 Any comprehensive strategy to address health care overuse must include messages for patients. 6 While the message might vary based on several factors, experts agree that key components to inform patients about health care services include the likelihood of acquiring and dying from the targeted disease; the benefits and harms of the health care service; and encouragement to make a decision about whether to have the service based on the patient's individual preferences and values. 7 The effectiveness of such messages is likely to be influenced by many factors, including their presentation format. Convincing literature 8 suggests that words describing probability do not have shared meaning and that the format of numbers has substantial impact on understanding and behavioral intention. 9,10 Furthermore, different narratives and framed presentation formats differentially affect these same outcomes. 11-13 However, to our knowledge, no studies have compared the effectiveness of these presentation formats in reducing intentions or behavior for low-value or potentially low-value screening services. Therefore, our goal was to examine the comparative effectiveness of 4 alternate formats for presenting benefits and harms information in reducing intentions for screening and changing secondary behavioral and decision-making outcomes for patients eligible for 1 of 3 low-value or potentially low-value screening services.
Methods

Study Overview and Setting
We conducted a randomized clinical trial in a convenience sample of four community-based practices (2 family medicine, 2 internal medicine), with 26 810 patients and 32 clinicians, that were affiliated with the Duke Primary Care Research Consortium (PCRC). The institutional review boards at the University of North Carolina and Duke University approved the study, and a data safety monitoring committee monitored the study. The trial protocol is provided in Supplement 1.
Participants and Their Recruitment
From weekly practice patient lists, study staff recruited a consecutive sample of individuals, ages 50 to 85 years, who received continuing care for more than 1 year at any of the participating PCRC sites, had an upcoming medical visit with their clinician, and were eligible to receive information about any 1 of the 3 screening services of interest. These services had either net harm at the population level (ie, prostate cancer screening in men ages 50-69 years) or small net benefit (making it likely that some individuals would benefit and some be harmed; ie, osteoporosis screening in low-risk women ages 50-64 years or colorectal cancer screening in men and women ages 76-85 years). We chose these services because they represent a spectrum of net benefit, encompass a variety of test types (a laboratory test, a procedural test, and a radiographic study), and are applied to a spectrum of adult patients. Because age groups did not overlap, each patient was eligible for only 1 service. Although we initially planned to include cardiovascular screening in low-risk men and women as an additional service, we dropped this service before recruitment given low numbers of eligible patients at study sites. Additional inclusion and exclusion criteria are published elsewhere. 14 We identified eligible patients for each service through electronic clinical records and consecutively sampled them until we reached target enrollment (n = 775). Patients provided written informed consent and were given $35 in compensation for participating. We stratified recruitment by site and service and attempted to recruit at least 25% of the sample with no prior screening for each service (although this was not always possible). We mailed letters to all potentially eligible patients and then followed up with up to 3 telephone calls to reach the patient and verify eligibility.
Procedures
Staff invited eligible participants to a study visit before or after a regularly scheduled physician's appointment or at a separate time if necessary. At the study visit, patients gave informed consent, completed a preintervention survey, and were assigned using central computerized randomization to 1 of 4 intervention arms for a single screening service. Randomization was stratified by site, screening service, and prior screening with allocation concealed from staff in a computerized database until after baseline survey completion. Patients were told only that they were participating in a study about how to best communicate with patients about screening. Patients read their 1 assigned evidence-based decision support sheet and completed postintervention surveys but did not discuss the materials with their clinicians.
Intervention
The intervention consisted of 1-page, written, evidence-based decision support sheets for each of the screening services. These were based on US Preventive Services Task Force (USPSTF) recommendations, [15] [16] [17] [18] were developed through an expert consensus process (that included 1 former USPSTF member), and were written at an eighth-grade reading level. Each sheet included a description of the disease for which screening could be undertaken (including disease incidence and mortality rates as derived from population estimates 19, 20 ), a description of the screening test and its benefits (primarily disease-specific mortality reduction), and harms (including physical and psychological harms across the screening cascade), 14 and encourage- The words presentation format used ordered descriptions for probabilities (eg, "many," "few," or "very few" people affected). The numbers format presented probabilities in a frequency format with a common denominator (x/1000) in text and a separate "facts box." Benefits were presented among those screened, and harms were presented among those treated, which may have presented a slightly more negative view of screening than if harms had been presented among those screened. The narrative format built on an approach that we previously used 24 and was designed to engage readers, inform them about the screening decision, and model the process of decision-making. 13 Narratives included (1) photographs of 4 racially diverse patients in the screening age group, and (2) text that showed individuals investigating the facts. The framed format was designed to dissuade screening. It used a gain frame to promote risk aversion and discourage screening instead of a loss frame to promote risk-seeking in the face of the risky option of screening to detect disease. The format presented the benefits of not screening (ie, harms avoided by not screening) rather than the harms of screening, which was presented in the other study arms. We tested the quantitative vignette during a linked qualitative study, revising it based on participant feedback. We then created the other intervention formats and tested them among administrative staff.
Measures
Study outcomes were intention to accept screening (primary outcome) and multiple decision-making and behavioral theory-related outcomes (secondary outcomes).
Primary Outcome
Intention is a measurable antecedent to behavior 25 and explains as much as 30% of variance in health behavior. 26 The survey measured intention to accept screening by assessing patients' plans to be screened for the service for which they were eligible during the usually recommended screening interval (1 year for prostate cancer screening, 5 years for osteoporosis screening, and 10 years for colon cancer screening). The 5-point response scale ranged from strongly disagree (coded as 1) to strongly agree (5).
Secondary Outcomes
General Screening Knowledge The survey assessed knowledge of key screening concepts using 8 items created by the study team that addressed: the definition of screening, false-positive results, false-negative results, overdiagnosis (3 questions regarding harmless disease and the need to live long enough and have effective treatments in order to benefit from screening), overtreatment, and the potential for harm. Response options were true, false, and don't know, with scoring based on total number of correct responses, from 0 to 8.
Disease-Specific Knowledge About Overdiagnosis and Harms
The survey assessed disease-specific knowledge using 2 items for each service that we adapted from prior work 27, 28 or, in the case of osteoporosis screening, we developed. For prostate screening, items were (1) "Some men can live long, normal lives with untreated prostate cancer"; and (2) "Problems with sexual function and urination are common side effects of prostate cancer treatments." For colorectal cancer screening, items were (1) "Most polyps in the bowel never become cancer"; and (2) "Bleeding and tears in the bowel are complications of a colonoscopy." For osteoporosis screening, items were (1) "Broken hip bones are uncommon before the age of 65"; and (2) "Treatments for osteoporosis can sometimes result in bone damage." Response options were true, false, and don't know, with scoring based on total number of correct responses, from 0 to 2.
Perceived Risk of Disease
The survey assessed patients' perceived risk of disease with a single question: "How likely is it that you will get disease x in the next 10 years?" The 4-point response scale ranged from not at all likely (coded as 1) to very likely (coded as 4).
Perceived Disease Severity
The survey assessed perceived severity of the disease using the Lay Perceptions of Serious Illnesses Scale that had 4 items assessing perceptions that the "disease is very serious," "has serious financial consequences," "affects the way the person sees himself as a person," and "causes difficulties for those close to the patient" (α .66). 29 The 5-point response scale ranged from strongly disagree (coded as 1) to strongly agree (5) . For this and the remaining multi-item measures, we averaged items to create a scale except as noted.
Positive Disease-Specific Screening Attitudes
The survey measured disease-specific screening attitudes using 6 items developed by investigators that assessed agreement that screening is a good idea in a healthy person of the patient's age, not a special responsibility (reverse coded), associated with little harm, owed to one's family or physician, and would be regretted if not done. The 5-point response scale ranged from strongly disagree (coded as 1) to strongly agree (5).
Perceived Net Benefit of Screening
We assessed perceived net benefit using a single question on decisional balance adapted from our previous work. 27 Respondents were instructed to think about how they felt at that moment about the decision to accept the screening in question. The 5-point response scale ranged from the harms greatly outweigh the benefits (coded as 1) to the benefits greatly outweigh the harms (5).
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Values Clarity
We assessed values clarity using the Values Clarity Subscale of the Decisional Conflict Scale that had 3 items that assessed whether patients agreed that they are clear about which benefits and harms matter most and whether benefits or harms are most important (α >.78). The 5-point response scale ranged from strongly agree (coded as 0) to strongly disagree (100), so that lower scores indicated greater clarity about personal values.
Self-efficacy for Screening
We measured self-efficacy for screening using a single item, for each type of screening that read "How confident are you that you could get screened for disease x if you wanted to?" The 5-point response scale ranged from not at all confident (coded as 1) to very confident (5).
Potential Moderators of Intervention Impact
To support exploratory analysis of moderators of the intervention's effect, we measured variables related to the ability and motivation to process information. These included education; numeracy (3 items, reported in aggregate as percentage correct, "Imagine that we flip a fair coin 1000 times. What is your best guess about how many times the coin would come up heads in 1000 flips?"; "In the lottery, the chance of winning the prize is 1%. If 1000 people each buy a single ticket to the lottery, how many people would win the prize?"; "In a publisher's sweepstakes, the chance of winning a car is 1 in 1000.
What percent of tickets in this sweepstakes win a car?") 30 ; need for cognition (3 items with the highest item-total correlations from an 18-item scale: "thinking is not my idea of fun"; "I would rather do something that requires little thought than something that is sure to challenge my thinking abilities"; and "I find satisfaction in deliberating hard and for long hours") 31 ; anticipated regret of not screening (1 item, reported on a 5-point scale from strongly disagree [1] to strongly agree [5] , "I would regret opting not to get screened if I later tested positive for disease.") 32 ; worry (3 items from the Illness Attitudes Scale, with responses on a 5-point scale from "no" [0] to "most of the time" [4] and summed from 0 to 12: "Do you worry about your health?"; "Are you worried you might get a serious illness in the future?"; "Does the thought of serious illness scare you?") 33 ; prior screening noted on medical chart review; and prior information (5 investigator-developed items with a common stem reported on 5-point scales from "never" [1] to "always" [5] and summed for a range of 1-25; items addressed exposure to screening information through newspapers, magazines, the Internet, television, or friends and family). We also assessed demographics.
Potential Harm of the Intervention
We monitored potential harms of our intervention by assessing increases in illness-related worry between preintervention and postintervention.
33
Other Preintervention-Only Measures As important characteristics of the sample, we also measured general screening attitudes using 11 items, in 2 subscales, developed and validated as part of this study rather than used as an outcome as originally planned (Jessica DeFrank, PhD, email communication, May 5, 2015) . These items were about the perceived benefits of screening (α .82) and feelings of duty or obligation to screen (α .84) and were correlated with intention for screening (r = 0.25 and r = 0.35, respectively).
Sample Size and Power
We calculated our sample sizes to be able detect a mean difference in pre-post changes in intention to accept screening of at least 0.5 points across intervention groups overall and within specific screening services. Based on prior work, we considered this 0.5 point difference the minimally clinically important difference in intention to accept screening services; this difference corresponds to a 21% reduction in screening intention. 34 Assuming 2-sided t tests with α = .001 and a standard deviation of change of 1, 35 we calculated that we would need 184 participants in each of the 4 intervention arms to give 95% power to detect this difference. This sample size provided about 80% power to detect a 0.5-point mean change in intention in subgroup analyses of the 3 screening services.
Statistical Analysis
We summarized sample characteristics using descriptive statistics. Per a priori plans, we tested the effectiveness of intervention formats on change in intention-to-accept screening in our overall sample, and subsequently in subgroups of screening services. We conducted analysis of covariance that included format as the key variable of interest, baseline intent for screening, and other covariates that differed among intervention arms. We compared several approaches for assessing change and found that all produced similar effects. 36,37 Similar analyses were conducted for secondary outcomes (using logistic regressions for binary outcomes). Per a priori plans, we first tested the difference between all study arms using an omnibus F test. If this test result was negative after accounting for multiple comparisons (in which we considered P <.001 significant), we did not pursue additional statistical testing between intervention arms. To examine potential moderators of the impact of the interventions on our primary outcome, we visually depicted moderation and added interaction terms to the models. To examine pre-post changes in primary and secondary outcomes, we used paired t tests for continuous outcomes and McNemar χ 2 tests for binary ones. Within subgroups of screening services, we repeated similar analyses (finding similar effects, thereby supporting our decision to combine analyses).
Results
Patient Characteristics
We enrolled and randomized 775 patients to the 4 intervention arms: words (n = 195), numbers (n = 192), narrative (n = 196), or framed (n = 192) formats (Figure 1) . Within each intervention arm, patients were distributed evenly across the 3 screening services. Baseline characteristics were mostly wellbalanced, although those in the framed format arm were
Intervention Effects
Primary Outcome: Change in Intention-to-Accept Screening The intervention arms had high intention-to-accept screening at baseline (words, 3.56; numbers, 3.71; narrative, 3.66; framed, 3.53 out of 5.00; Table 2 ). The 4 intervention arms did not differ in change in screening intentions (adjusted P = .57).
In analyses within each arm, the narrative format had lower intention-to-accept screening at postintervention compared with preintervention (−0.12; 95% CI, −0.22 to −0.02 on a 5-point scale), but other interventions arms had no changes from baseline. In separate subgroup analyses for the 3 screening services, we observed a similar pattern of findings (see Table 2 and eTables 5-7 in Supplement 2).
Secondary Outcomes
Overall and subgroup analyses found no statistically significant differences in change in intention for screening across intervention arms for any of the secondary study outcomes after accounting for multiple comparisons. However, within intervention arms, some secondary outcomes improved from baseline (eg, screening knowledge, screening attitudes, and perceived net benefit of screening; see Table 2 and eTables 5-7 in Supplement 2).
Moderators
In the overall sample, change in intention for screening did not differ across study arms for subgroups of patients defined by ability, motivation, or demographics ( Figure 2 ).
Potential Harm of the Intervention
We observed no evidence of increase in postintervention illness-related worry.
Discussion
In a randomized clinical trial of 4 formats for presenting benefits and harms of 3 screening services with low-value or potentially low-value, we found no differences in change in intention for screening across intervention arms. Furthermore, while secondary outcomes showed small improvements from baseline, none of these changes were sufficient to change intentions to accept screening. There were no clinically important differences in subgroups of patients defined by ability, motivation, or demographics and no evidence of harm from the interventions.
Our findings are consistent with those of systematic reviews 38 showing that patient decision aids produce increases in screening knowledge and improve other decisionmaking outcomes; however, they also suggest that single, brief, written decision support sheets, such as those used in this trial, are unlikely to be sufficient to change intention for screening of low-value or potentially low-value screening services, regardless of their format. Decisions about screening are driven by a complex interplay of attitudes, social norms, and selfefficacy, many of which often strongly favor screening. Furthermore, many decision-makers rely on emotions and heuristic decision-making, rather than the rational processes involved in weighing harms and benefits, and are subject to a host of cognitive biases that make foregoing health care services difficult. 14, 39, 40 This suggests that either more inten- sive interventions or new approaches will be needed. More intensive decision support interventions for prostate cancer screening have been shown to reduce screening intentions and behavior (one by 22% at 9 months), 24,41 likely through their inclusion of more detailed information and additional components such as modeling self-discovery about harms. Such interventions may have an important role in reducing screening intentions for low-value services. However, even more intensive interventions may not be enough.
Rather than simply intensifying current clinical interventions, effective approaches to reducing overuse of low-value services may need to take a comprehensive approach. The most successful campaigns have targeted multiple levels of the public health pyramid. 6 It may be that prevention and deimplementation of low-value care will require combinations of interventions such as (1) patient and clinician engagement through campaigns, like Choosing Wisely; (2) aligned recommendations and incentives 42, 43 ; (3) committed leaders and champions; (4) the time and space for change; (5) system-level supports 42, [44] [45] [46] [47] ; and (6) more intensive clinician and patient decision support than the 1-page written decision support sheets provided in this study. 24, 48 Possible adjunctive decisionmaking interventions include highlighting the financial and opportunity costs of screening, emphasizing the potential harms of overdiagnosis and overtreatment, 49 increasing the salience of harms through video or other media, and testing appeals to (2) 5 (3) 3 (2) 8 (4) 1 (<1)
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Perceived net benefit, range 1-5; 5 = benefit greatly outweighs harms Overall, the study showed no significant change in intention to screen preintervention to postintervention and no difference between the 4 formats. Addressing an important clinical and public health issue, the investigators and JAMA Internal Medicine are commended for publishing these null findings. We interpret the findings herein with consideration of the study's patient sample, risk communication strategy, and evaluation methods, and identify potential future research directions.
Described as a convenience sample, participants averaged 65 years of age, were highly educated (>90% were college educated, many with advanced degrees), nearly all insured, and all receiving continuity care within 4 selected community-based, primary care practices. Despite attempts to recruit patients not screened previously, most had in the past completed the screening tests of interest (>80% for PSA and nearly 100% for colorectal cancer screening). Just over onethird (39%) of invited eligible patients enrolled. No financial incentive was provided for study participation. Patient factors predictive of study enrollment were not reported. It is likely that interest in screening related to participation. Notably, the sample's intention for screening at baseline was characterized as high. Unknown is how study findings generalize to younger, more socioeconomically disadvantaged groups, and those without interest and prior screening experience.
The primary outcome was patient self-reported intention to accept future screening, not medical chart documentation of actual screening behavior. The investigators 2 acknowledged that intention is an incomplete measure, predicting a maximum of 30% variance in behavior. Research 3, 4 in various wide-ranging fields has consistently found that past behavior is the best predictor of future behavior. It is unsurprising then that in a patient group compliant in the past with clinician screening recommendations, the effect of this lowintensity patient-focused intervention would be null.
Some points are worth mentioning with regard to the risk communication approach. Although aimed at reducing acceptance of screening, the study materials used gain-framed messaging (eg, foregoing a PSA test would avoid biopsy, worry, and unnecessary treatments). Best practices suggest the utility of gain-framed messages for promoting behavior and lossframed messages for reducing a behavior. 5 The decision aids emphasized the problem of overdiagnosis, represented indirectly with reference to how incident disease rates exceed clinically important outcomes, such as mortality or fractures. While the quantified benefits were reported for the number of patients screened (eg, 1 fewer death in every 1000 men screened), the event rates for treatment complications applied only to treated patients (eg, 300 of 1000 men treated have sexual dysfunction and urinary tract problems), which the investigators 2 acknowledged likely portrayed an overly negative view of screening. The investigators 2 pilot tested only the quantitative vignette with patients; unknown is the degree to which patients noted and appreciated the subtle differences in each risk communication format. Finally, the materials were static without tailoring to patient race or ethnicity, personal or family medical history (eg, cancer, fractures), prior screening behavior, or current intention. Research generally has found that patients have greater recollection for and are more responsive to tailored health communications. 6 Process measures that would have been useful to collect include the amount of time patients spent reading the material and comprehensibility and perceived usefulness of the information. Also of interest are clinician effects. The study's focus was on patient acceptance of screening, which ostensibly would be recommended by their health care clinicians. Unmentioned were efforts to attenuate clinician recommendation for low-value screening practices. In the literature, standardized protocols, group education, alert systems with reminders, and
